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The genome sequence of the human malaria parasite, Plasmodium falciparum, was released almost a decade ago. A majority of the
Plasmodium genome, however, remains annotated to code for hypothetical proteins with unknown functions. The introduction
of forward genetics has provided novel means to gain a better understanding of gene functions and their associated phenotypes
in Plasmodium. Even with certain limitations, the technique has already shown signiﬁcant promise to increase our understanding
of parasite biology needed for rationalized drug and vaccine design. Further improvements to the mutagenesis technique and the
designofnovelgeneticscreensshouldleadustosomeexcitingdiscoveriesaboutthecriticalweaknessesof Plasmodium,andgreatly
aid in the development of new disease intervention strategies.
1.Introduction
Malaria is a serious global health problem causing clinical
illness in hundreds of millions of people and killing around
am i l l i o n ,e a c hy e a r[ 1]. Intervention strategies to control
the disease have been largely ineﬀective due to increased
parasite drug resistance, ineﬀective vector control measures,
and inadequate knowledge about parasite biology to identify
new drug and vaccine targets. The need to discover critical
weaknesses in the parasite that could be exploited in design-
ingnovelantiparasiticstrategiesisgreaterthanever.Sincethe
release of the Plasmodium genome sequence, several large-
scalefunctionalstudieshaveadvancedouroverallknowledge
tremendously about parasite biology [2–6]. However, in
spite of such enormous eﬀorts, almost 50% of the genome
remains annotated to code for hypothetical proteins in all
Plasmodium species [7]. It is imperative to understand the
functions and essentiality of these hypothetical proteins to
facilitate the identiﬁcation of novel drug or vaccine targets.
2.Difﬁculties inPlasmodium Genetics
Theﬁrstandforemostobstacleinfunctionalcharacterization
of the Plasmodium genome is our limited ability to geneti-
cally manipulate the parasite [8]. Out of all the Plasmodium
species that cause human malaria, only the blood stages of
P. falciparum can be cultured in vitro eﬀectively and is the
only life cycle stage amenable to transfection with exogenous
DNA. While electroporation is most eﬀective in transfecting
P. falciparum [9, 10], the transfection eﬃciency is very low,
in the range of 10−6 [11]. The rodent malaria parasite,
P. berghei, can be transfected with much higher eﬃciency
and, therefore, has been used more extensively in targeted
gene knockout studies [12]. Furthermore, transfections in
P. falciparum are limited to circular plasmid DNA and the
parasite’s ability to maintain these plasmids as episomes
makes it diﬃcult to isolate the rare genomic integration
events [13, 14]. Lastly, the parasite’s haploid genome in the
blood stages limits manipulation and identiﬁcation of genes
essential for parasite development.
3. Reverse Genetics versus Forward Genetics
There are two possible approaches to functional character-
ization of a genome: (1) a reverse genetic approach, where
a gene of interest is disrupted and the resulting phenotype
is studied and (2) a forward genetic approach, where a
phenotype of interest is ﬁrst chosen and a pool of randomly
generated mutants is subjected to a screen for the phenotype2 Journal of Tropical Medicine
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Figure 1: A schematic representation of forward and reverse genetic approaches for genetic association of phenotypes. Reverse genetics
starts with the selection of gene of interest and culminates with the phenotypic analysis of its disruption. Forward genetics starts by selecting
a phenotype of interest and ends in identifying gene(s) responsible for that phenotype.
of interest (Figure 1). Both these approaches have been
equally eﬀective, depending on the organism studied [15–
18]. Functional characterization of the yeast genome is a
great example of a successful reverse genetic approach [19].
A genome-wide knockout study has been feasible in yeast
because of the ease of introducing exogenous DNA and the
high eﬃciency of homologous recombination, and a large
amount of phenotypic information is currently available for
each gene knockout [20]. In higher organisms such as the
fruit ﬂy, forward genetic screens using transposon-mediated
insertional mutagenesis have been preferred and have pro-
vided great information regarding gene functions [21–23].
A recent branch of forward genetics using small molecules
has been very promising in many organisms, including
Plasmodium [24–28]. Such chemical genetic approaches
directlyinhibitproteinfunctionandareoftenreversible.This
paper will focus speciﬁcally on a transposon-based forward
genetic approach and its applications in Plasmodium.
4.Transposon-Mediated
Mutagenesis in Plasmodium
4.1. Rationale. Reverse genetic studies in Plasmodium,e s p e -
cially in the most lethal human malaria parasite P. falcipa-
rum,h a v eb e e nh a m p e r e db yl o we ﬃciencies of transfec-
tion and homologous recombination [8]. Although a few
medium-scalegeneknockoutapproacheshavebeenattempt-
ed in P. falciparum, they were extremely tedious, labor
intensive,andfallmuchshortofthegenome-wideknockouts
needed for rationalized drug and vaccine design [29, 30].
Forward genetic studies might oﬀer a quicker and more
eﬃcient way to characterize the Plasmodium genome. The
transposition event, which includes ﬁnding one target se-
quence from hundreds of thousands in the genome, should
be much more eﬃcient than homologous recombination at a
singlelocusinthegenome.Performinggeneticscreensmight
thusbefasterandmoreeﬀectiveinidentifyinggenesinvolved
in critical biological processes of the parasite.
The piggyBac transposable element has been used exten-
sively for insertional mutagenesis in numerous invertebrate
and vertebrate species [31–35]. The ability to transmobilize
piggyBac, through separate expression of the piggyBac trans-
posase, has immensely contributed to the wide adaptability
of the system to multiple organisms [36]. piggybac’s ability
tomorerandomlyinsertintothegenome,comparedtoother
transposable elements, increases the likelihood of achieving
genome-wide insertions and supports its application in
insertional mutagenesis studies [35]. The target site for
piggyBac insertion is TTAA and more than 300,000TTAA
target sites can be found in the AT-rich Plasmodium genome,
providing a platform for genome-wide mutagenesis [37].
4.2. Methodology. The piggyBac system was ﬁrst successfully
adapted to P. falciparum [38] and has recently been extend-
edtoP.berghei[39].ThebasicdesignforpiggyBac insertional
mutagenesis in Plasmodium uses a two-plasmid approach.
The ﬁrst plasmid consists of a Plasmodium drug selection
cassette ﬂanked by the piggyBac 5  and 3  terminal repeats,
and the second plasmid drives the expression of the pig-
gyBac transposase, required for the enzymatic cleavage and
genomic insertion of the piggyBac terminal repeats (Figure
2). The transposase plasmid lacks a drug-selection cassette
and is lost in a few generations, thereby preventing contin-
uous movement of piggyBac.I nP. berghei, a transgenic line
containing the piggyBac transposase in the genome was also
shown to be very eﬀective in insertional mutagenesis and
remobilization of previously inserted piggyBac element [39].
The precise insertion and excision mechanisms of piggyBac
leave no footprints behind following remobilization, allow-
ing phenotype rescue of any knockout [34].
4.3. Eﬃciency of piggyBac Mutagenesis in Plasmodium. pig-
gyBac insertions into the genome can be obtained within 3-
4 weeks in P. falciparum compared to 6–12 months needed
to obtain homologous recombination events, and 1–10
insertions canbe obtained pertransfectiondepending on theJournal of Tropical Medicine 3
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Figure 2: Basic plasmid designs for piggyBac mutagenesis in Plasmodium. The donor plasmid consists of a Plasmodium drug selection
cassette ﬂanked by the terminal repeats (TR) of piggyBac. The helper plasmid provides the piggyBac transposase, which mediates the trans-
position event into the Plasmodium genome upon cotransfection with the donor plasmid.
conditions used [38]. Genomic insertions of piggyBac can be
obtained in much higher numbers in P. berghei due to its
increased transfection eﬃciency. Analyses of approximately
200 piggyBac insertion sites in P. falciparum and 120 in P.
berghei show an almost equal distribution in the coding
and noncoding regions of the genome, as predicted by the
equal distribution of TTAA target sites in both coding and
noncoding regions [39, 40]. This is an important ﬁnding
considering the higher AT-richness in the noncoding regions
ofthegenome.Whileaslightbiaswasobservedforinsertions
into the 5  untranslated regions (UTRs) of genes in the
initial study in P. falciparum, this bias was most likely due
to the higher growth rate of clones with insertions in UTRs
compared to those with insertions in coding sequences, in
a mixed population of transformed parasites, and this bias
for 5  UTRs was not observed in experiments where the
transfection was followed by immediate cloning of parasites
(Balu and Adams, unpublished data).
Thereappearstobenostrikingbiasforinsertionintoany
particular chromosome or chromosomal region. Further-
more, piggyBac inserts into genes of all functional categories
and shows no signiﬁcant preference for genes expressed
in the transformed blood stages. An equivalent number
of piggyBac insertions were observed in genes exclusively
expressed in other parasite life cycle stages, indicating the
accessibilitytothesegenesintheparasite’sbloodstages.Such
observations conﬁrm the randomness of piggyBac insertions
and demonstrate its eﬀectiveness as a tool for genome-wide
insertionalmutagenesisinPlasmodium.Additionally,inboth
P.falciparumandP.berghei,mostlysinglepiggyBac insertions
are obtained per genome, allowing easy correlation of
genotypes to their respective phenotypes [39, 40].
4.4. Applications of piggyBac Mutagenesis. The most ben-
eﬁting application of insertional mutagenesis will be the
ability to perform forward genetic screens to identify genes
contributing to a phenotype of interest. A medium-scale
forwardgeneticscreenusingapproximately200P.falciparum
piggyBac insertional mutants was able to identify several
genes and pathways crucial for intraerythrocytic develop-
ment of the parasite [41]. Although genes essential for in
vitro intraerythrocytic development could not be identiﬁed
due to the haploid genome, mutants with reduced growth
rates of up to 70% could be isolated. It is also important
to realize that many of the genes aﬀected in these severely
attenuated mutants might be essential for in vivo develop-
ment, as the host immune system might eﬀectively clear a
slowly spreading infection. For example, disruption of the
P. falciparum ccr4-not associated factor 1 (caf1) results in
severe attenuation of intraerythrocytic growth in vitro but,
despite multiple attempts, thegene remains refractoryto dis-
ruption in P. berghei, suggesting its essentiality in vivo [42].
Another key ﬁnding of this forward genetic study in
P. falciparum is the signiﬁcance of nucleic acid binding
and nucleic acid metabolism genes in intraerythrocytic
development [41]. A majority of genes in this category
includes RNA-binding proteins that play a potential role
in posttranscriptional gene regulatory mechanisms, thus
identifying this process as a high-value target for therapeutic
intervention. A follow-up investigation of one of the genes
identiﬁed in this study substantiates the potential of forward
genetic screens in Plasmodium (Figure 3). Functional char-
acterization of the caf1 null mutant reveals a critical role for
thisge neint e mpo ralge ner egulatio ninP.falciparum,andits
disruption leads to premature egress from host cells, severely
attenuating the intraerythrocytic growth rate [42], providing
valuable insights into a largely unknown but critical parasite
biological process. Further characterization of this gene reg-
ulatorypathwaymightidentifyothercrucialparasite-speciﬁc
proteins with great potential as antimalarial drug targets.
While transposon-mediated mutagenesis does not oﬀer
a direct way to identify essential genes in the haploid
blood stages, its ability to rapidly identify nonessential re-
gions of the genome will be signiﬁcant in directing our
antimalarial drug discovery eﬀorts. Genes that show no
reduction in intraerythrocytic growth rate upon disruption
can be immediately discarded from consideration as putative
intraerythrocyticdrugtargets.However,theirexpressionand
functions in other life cycle stages should be considered for
transmission-blocking strategies or for targeting the parasite
liver stages.
piggyBac oﬀers an excellent vehicle for stable transgene
expression in Plasmodium without constant drug pressure,
which would be required during episomal expression [43–
45]. Moreover, insertions in the noncoding regions that do
not aﬀect parasite growth can be readily obtained for use in
drug-response assays. Expression of parasite proteins as GFP
fusions using piggyBac allows subcellular localization studies
to be performed with ease [44]. Since the insertions are
stably maintained in the genome, genes expressed in other
parasite life cycle stages can also be studied. DNA sequences
up to 7kb in length including the drug selection cassette
can be inserted into the genome quite eﬃciently; however,
longer sequences might require higher levels of transposase
for eﬃcient insertion. Most importantly, any parasite line
of interest can be readily transformed with piggyBac unlike4 Journal of Tropical Medicine
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Figure 3: An example of a successful forward genetic approach in P. falciparum. A screen for attenuated intraerythrocytic growth indicates
thesigniﬁcance ofpost-transcriptionalgeneregulationinthesestages.Functionalcharacterization ofCCR4-AssociatedFactor 1hasrevealed
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ATc-regulated
promoter
ATc-regulated
promoter
ATc-regulated
promoter
ATc-regulated
promoter
ATc-regulated
promoter
ATc-regulated
promoter
Drug selection cassette
Drug selection cassette
Drug selection cassette
Transcription ON
Transcription OFF
Gene
Gene
ATc
EP
EP
genome
pigg
Plasmodium
genome Plasmodium
genome Plasmodium
yBac plasmid
TR 1
TR 1
TR 1
TR 2
TR 2
TR 2
Test for essentiality
Insertion into
+ Anhydrotetracycline
(ATc)
Figure 4: A putative scheme for identifying essential genes in Plasmodium using piggyBac mutagenesis. The piggyBac plasmid containing
two anhydrotetracycline-(ATc-) regulated promoters, one near each terminal repeat (TR), can be ﬁrst inserted into the Plasmodium genome.
Upon insertion into the 5  region of a gene, its endogenous promoter (EP) will be replaced by the ATc-regulated promoter. Addition of ATc
will block transcription of the gene, allowing the evaluation of its essentiality.
the mycobacteriophage Bxb1-based system, where genomic
insertion of phage recombination sites through homologous
recombination is a prerequisite to stable expression [46].
Promotertrappingusingtransposableelementsprovided
very useful information about gene expression in higher
eukaryotes [47, 48]. Promoter trapping has been possible in
both P. falciparum and P. berghei using piggyBac [37,
39]. However, in the current era of large-scale functional
genomics, whole-genome transcriptome and other expres-
sion studies have provided abundant information about
timing and levels of gene expression in Plasmodium and
the information obtained from promoter trapping might beJournal of Tropical Medicine 5
insigniﬁcant. Also, while promoter trapping can help dete-
rmineactivepromoters,itcannotidentifytheexactpromoter
region, which would still have to be determined through
conventional reporter assays.
5. FutureDirections
While the ability to obtain genomic integrations is tremen-
dously high with piggyBac compared to homologous recom-
bination, we are still faced with the challenge of low
transfection eﬃciency in Plasmodium. Successful forward
genetic screens in other organisms usually involve achieving
a “saturation” level of mutagenesis, where every gene in the
genome has been perturbed in a single experiment. This
might not be possible even in P. berghei, which can be
transfected at a much higher eﬃciency than P. falciparum
and where remobilization of piggyBac can be achieved. One
should also be wary of the complications that could arise in
correlating genotypes to phenotypes in case of uncontrolled
remobilization events, and tight regulation of remobilization
events will be a necessity for increasing genomic integration
events without repeated transfections.
Increasing the mutant pool available for screens is of
high priority for the future. Since almost half of the piggyBac
insertions occur in noncoding regions, they may or may not
aﬀect gene expression. The most direct information from
forward genetic screens can be obtained by using mutants
with disrupted coding sequences, and obtaining as many
of them as possible should be one of the prime objectives.
Instead of overly speculating about reaching saturation level
mutagenesis, the number of experiments needed to disrupt
a signiﬁcant number of genes, and comparison of trans-
formation eﬃciencies with higher eukaryotes, it might be
most beneﬁcial to understand the limitations of Plasmodium
genetics and make the best use of this system by generating a
large number of single insertional mutant clones that could
be used in screens. Performing screens in a mixed popula-
tion of mutants, even if saturation level mutagenesis were
possible, would present several challenges in Plasmodium.
Negative phenotypic screens, such as attenuated growth, fail-
ure to produce gametocytes, and inability to infect the mos-
quito vector, will be of highest interest but extremely diﬃcult
to perform and tease out in mixed populations. Even if the
phenotype were narrowed down to a set of genes, the lack of
robust genetic complementation tools would severely limit
further characterization.
Considerable attention must also be given to developing
new genetic screens targeted towards the many intriguing
features of parasite development and pathogenesis. For ex-
ample, phenotypic screens for adherence to endothelial cells,
which is a critical component of disease pathogenesis, could
identify novel mediators of this process. Screens directed
towards the development of other parasite life cycle stages,
such as gametocytes and sporozoites, should provide novel
candidates for transmission-blocking strategies and con-
tribute immensely to disease control and prevention strate-
gies.
The biggest limitation of insertional mutagenesis in Plas-
modium is the inability to mutate and identify genes essential
forbloodstagedevelopment,asonlythehaploidbloodstages
of the parasite can be transfected. To overcome this deﬁ-
ciency,novelexperimentaldesignsthatcombinethepiggyBac
system with a conditional expression system such as the
anhydrotetracycline-(ATc-) regulated system [49], need to
be developed. One could envision placing the ATc-regulated
promoterinbetweenthepiggyBac terminalrepeatssuchthat,
upon insertion into the genome, it replaces an endogenous
promoter but is still able to drive the expression of the
downstream gene (Figure 4). Addition of ATc would turn oﬀ
the expression of the downstream gene and its essentiality
in blood-stage development could be evaluated. However,
several factors would need to be considered for such an
approach to work. Since piggyBac terminal repeats could be
inserted into the genome in either orientation, it might be
best to place two ATc-regulated promoters in between the
piggyBac terminal repeats, one near each terminal repeat
(Figure 4). The eﬀectiveness of this system will depend upon
its insertion in the 5  UTR of a gene, and the similarity
between the timing of expression from the ATc-regulated
promoter and the endogenous promoter. Furthermore, the
robustness of the ATc-regulated system would need to
be tested as leaky expression through the ATc-regulated
promoter would hinder the identiﬁcation of essential genes.
More robust systems using Plasmodium-speciﬁc factors
might be required for tight regulation of gene expression.
Insummary,theintroductionoftransposonmutagenesis
to Plasmodium has provided new exploratory avenues to
study this important parasite. With further reﬁnement of
the system and an increase in the mutant pool, a variety of
forward genetic studies should be feasible and provide excit-
ingdiscoveriesaboutthemalariaparasite’senigmaticbiology
that could be exploited for developing novel antimalarial
strategies.
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